Voloridge Investment Management
TVRD

Voloridge Investment Management’s Tvardi Therapeutics TVRD Stock Holding History

Voloridge Investment Management’s Portfolio TVRD Stock Details TVRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,747
Closed -$898K – 1912
2021
Q2 		$898K Buy
+1,747
New +$1.11M 0.01% 1291
2020
Q3 		– Sell
-512
Closed -$315K – 1547
2020
Q2 		$315K Buy
512
+101
+25% +$55.8K ﹤0.01% 1126
2020
Q1 		$195K Buy
+411
New +$223K 0.01% 959
2017
Q2 		– Sell
-2,857
Closed -$1.89M – 613
2017
Q1 		$1.89M Buy
+2,857
New +$1.53M 0.05% 323

Other funds holding TVRD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Voloridge Investment Management's TVRD Position: Q3 2021 in Review

Voloridge Investment Management sold out of Tvardi Therapeutics (TVRD) in Q3 2021, closing a stake of 1,747 shares — an estimated $898K sold.

Voloridge Investment Management first reported a position in TVRD in Q1 2017 and held it in 4 quarters. The position peaked at $1.89M in Q1 2017. 169 funds tracked by Wall St. Rank hold TVRD as of Q3 2021.

  • Voloridge Investment Management reported no remaining Tvardi Therapeutics position as of Q3 2021 after selling out during the quarter.
  • Voloridge Investment Management sold 1,747 Tvardi Therapeutics shares in Q3 2021, an estimated $898K.
  • Voloridge Investment Management first reported a position in Tvardi Therapeutics in Q1 2017 and held it in 4 quarters.
  • Voloridge Investment Management's Tvardi Therapeutics position peaked at $1.89M in Q1 2017.
  • 169 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q3 2021.

Based on Voloridge Investment Management's 13F filing for Q3 2021, filed 15 Nov 2021.